Edoxaban treatment in atrial fibrillation in routine clinical care: One‐year outcomes of the prospective observational ETNA‐AF study in South Korean patients

BACKGROUND: The real‐world outcomes of edoxaban treatment in patients with atrial fibrillation (AF) were analyzed in the ETNA‐AF (Edoxaban Treatment in Routine Clinical Practice) study involving data from multiple regional registries. This report addresses effectiveness and safety of edoxaban in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Eue‐Keun, Choi, Jong‐Il, Park, Hyoung‐Seob, Hwang, Gyo‐Seung, Joung, Boyoung, Kim, Jong‐Youn, Kim, Dae‐Hyeok, Shin, Dong Gu, Park, Hyung Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407161/
https://www.ncbi.nlm.nih.gov/pubmed/37560283
http://dx.doi.org/10.1002/joa3.12878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10407161/
https://www.ncbi.nlm.nih.gov/pubmed/37560283
http://dx.doi.org/10.1002/joa3.12878

Ejemplares similares